These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16611409)

  • 1. (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo.
    Wolter KG; Wang SJ; Henson BS; Wang S; Griffith KA; Kumar B; Chen J; Carey TE; Bradford CR; D'Silva NJ
    Neoplasia; 2006 Mar; 8(3):163-72. PubMed ID: 16611409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
    Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
    Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.
    Zerp SF; Stoter TR; Hoebers FJ; van den Brekel MW; Dubbelman R; Kuipers GK; Lafleur MV; Slotman BJ; Verheij M
    Radiat Oncol; 2015 Jul; 10():158. PubMed ID: 26223311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
    Bauer JA; Trask DK; Kumar B; Los G; Castro J; Lee JS; Chen J; Wang S; Bradford CR; Carey TE
    Mol Cancer Ther; 2005 Jul; 4(7):1096-104. PubMed ID: 16020667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
    Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
    Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
    Alhazzazi TY; Kamarajan P; Xu Y; Ai T; Chen L; Verdin E; Kapila YL
    Anticancer Res; 2016 Jan; 36(1):49-60. PubMed ID: 26722027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells.
    Li H; Piao L; Xu P; Ye W; Zhong S; Lin SH; Kulp SK; Mao Y; Cho Y; Lee LJ; Lee RJ; Lin YC
    Pharm Res; 2011 Dec; 28(12):3256-64. PubMed ID: 21710341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
    Xu L; Yang D; Wang S; Tang W; Liu M; Davis M; Chen J; Rae JM; Lawrence T; Lippman ME
    Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
    Shao F; Lv M; Zheng Y; Jiang J; Wang Y; Lv L; Wang J
    Biochimie; 2015 Dec; 119():183-91. PubMed ID: 26549486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
    Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA
    Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations.
    Zhao R; Zhou S; Xia B; Zhang CY; Hai P; Zhe H; Wang YY
    BMC Cancer; 2016 Jul; 16():491. PubMed ID: 27431492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
    Gu X; Song X; Dong Y; Cai H; Walters E; Zhang R; Pang X; Xie T; Guo Y; Sridhar R; Califano JA
    Clin Cancer Res; 2008 Mar; 14(6):1840-8. PubMed ID: 18347187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of AT-101 (R-(-)-gossypol acetic acid) in androgen-independent growth of VCaP prostate cancer cells in combination with surgical castration.
    Loberg RD; McGregor N; Ying C; Sargent E; Pienta KJ
    Neoplasia; 2007 Dec; 9(12):1030-7. PubMed ID: 18084610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma.
    Yin X; Hayes DN; Shores CG
    Head Neck; 2011 Aug; 33(8):1106-14. PubMed ID: 20967867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.